NVCT

NVCT R&D Expenses

$19.65MTTM · USD

Period ending:

NVCT FY R&D ExpensesUSD
NVCT FY R&D Expenses2020-12-31: $0.002021-12-31: $9.55M2022-12-31: $13.23M2023-12-31: $15.38M2024-12-31: $12.92M2025-12-31: $18.15M$18.15M$0.00
2020-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

NVCT r&d expenses history

Research and development spending. The available annual fiscal periods series contains 6 observations from Dec 31, 2020 to Dec 31, 2025.

Nuvectis Pharma Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
18,153,000
12,918,000
15,380,000
13,227,000
9,545,000
0

Compare r&d expenses

All NVCT financial metrics · NVCT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.